Journey Medical Corp. (DERM)
7.47
-0.06
(-0.80%)
USD |
NASDAQ |
Aug 28, 16:00
7.41
-0.06
(-0.80%)
After-Hours: 20:00
Journey Medical Free Cash Flow : -7.567M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.567M |
| March 31, 2026 | -6.775M |
| December 31, 2025 | -12.52M |
| September 30, 2025 | -18.93M |
| June 30, 2025 | -17.71M |
| March 31, 2025 | -21.94M |
| December 31, 2024 | -24.13M |
| September 30, 2024 | -27.78M |
| June 30, 2024 | -7.877M |
| Date | Value |
|---|---|
| March 31, 2024 | 1.177M |
| December 31, 2023 | 0.24M |
| September 30, 2023 | 12.83M |
| June 30, 2023 | -13.20M |
| March 31, 2023 | -20.37M |
| December 31, 2022 | -33.53M |
| September 30, 2022 | -34.10M |
| June 30, 2022 | -28.52M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Nektar Therapeutics | -234.03M |
| ANI Pharmaceuticals, Inc. | 167.52M |
| Corcept Therapeutics, Inc. | 106.92M |
| Veru, Inc. | -26.04M |
| Johnson & Johnson | 22.61B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.734M |
| Cash from Financing (Quarterly) | 0.158M |
| Free Cash Flow Per Share (Quarterly) | -0.0631 |
| Free Cash Flow to Equity (Quarterly) | -1.808M |
| Free Cash Flow to Firm (Quarterly) | -0.7822M |
| Free Cash Flow Yield | -3.79% |